Inflammatory cytokines such as IL-6, derived from bone marrow (BM), mediate BCL2, BCLXL, and MCL1 expression in MM, forming complex network interactions between the marrow stroma and myeloma cells (63–65). This evidence concerns the gene BCL2 and plasma cell myeloma.